CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
16 results
Search Results
Now showing 1 - 10 of 16
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Global health education programs: Are we embedding contemporary global health needs into the curriculum of master’s programs?(Frontiers Media SA, 2026-01-09) ;Samraj Singh Bhullar ;Antonia Roberts; ;Edward Mezones-HolguínAli Al-kassab-Cordova<jats:sec> <jats:title>Introduction</jats:title> <jats:p>Global health education (GHE) is expected to prepare professionals to address complex, interlinked global challenges. However, current GHE structures often reflect persistent power asymmetries between the Global North and South, limiting the development of a truly global and equitable health workforce. This review examines how global health master’s programs are distributed geographically and to what extent their thematic focus and core curricular content reflect current global health priorities, particularly those related to equity and social justice.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>A mapping review of 86 graduate-level GHE programs worldwide was conducted to examine their geographic distribution, thematic focus, and curricular content. Programs were categorized by region and analyzed for thematic emphasis and pedagogical approaches, based on publicly available information on modules and learning activities.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>The review found that 84% of GHE programs are offered by institutions in the Global North. Programs in the Global South are fewer but tend to emphasize environmental health, governance, and community engagement, often incorporating experiential learning. Across all regions, key topics such as health systems, global health challenges, sustainability, law, ethics, and human rights are unevenly integrated. This variability risks producing graduates with inconsistent competencies to address global health priorities. The dominance of Global North institutions in GHE reflects broader structural inequities in global health. While emerging North–South and South–South collaborations and field-based learning suggest a shift toward more reciprocal models, many programs lack clearly defined aims and accountability frameworks.</jats:p> </jats:sec> <jats:sec> <jats:title>Discussion</jats:title> <jats:p>To advance GHE, curricula must embed equity, interdisciplinarity, and regional relevance. Explicit learning outcomes should include power analysis and partnership-building, co-designed and co-delivered with institutions and communities from both the Global North and South. Such reforms are essential to cultivate a workforce capable of addressing global health challenges with contextual sensitivity and systemic insight.</jats:p> </jats:sec>2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Differential Effects of a Telemonitoring Platform in the Development of Chemotherapy-Associated Toxicity: A Randomized Trial Protocol(2024) ;Felipe Martínez ;Carla Taramasco ;Manuel Espinoza; Carolina Goic<jats:p>Chemotherapy requires careful monitoring, but traditional follow-up approaches face significant challenges that were highlighted by the COVID-19 pandemic. Hence, exploration into telemonitoring as an alternative emerged. The objective is to assess the impact of a telemonitoring platform that provides clinical data to physicians overseeing solid tumor patients, aiming to enhance the care experience. The methodology outlines a parallel-group randomized clinical trial involving recently diagnosed patients with solid carcinomas preparing for curative intent chemotherapy. Eligible adult patients diagnosed with specific carcinoma types and proficient in Spanish, possessing smartphones, will be invited to participate. They will be randomized using concealed allocation sequences into two groups: one utilizing a specialized smartphone application called Contigo for monitoring chemotherapy toxicity symptoms and accessing educational content, while the other receives standard care. Primary outcome assessment involves patient experience during chemotherapy using a standardized questionnaire. Secondary outcomes include evaluating severe chemotherapy-associated toxicity, assessing quality of life, and determining user satisfaction with the application. The research will adhere to intention-to-treat principles. This study has been registered at ClinicalTrials.gov (NCT06077123).</jats:p>4Scopus© Citations 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effects on Quality of Life of a Telemonitoring Platform amongst Patients with Cancer (EQUALITE): A Randomized Trial Protocol(2024) ;Felipe Martínez ;Carla Taramasco ;Manuel Espinoza; Carolina Goic<jats:p>Cancer, a pervasive global health challenge, necessitates chemotherapy or radiotherapy treatments for many prevalent forms. However, traditional follow-up approaches encounter limitations, exacerbated by the recent COVID-19 pandemic. Consequently, telemonitoring has emerged as a promising solution, although its clinical implementation lacks comprehensive evidence. This report depicts the methodology of a randomized trial which aims to investigate whether leveraging a smartphone app called Contigo for disease monitoring enhances self-reported quality of life among patients with various solid cancers compared to standard care. Secondary objectives encompass evaluating the app’s impact on depressive symptoms and assessing adherence to in-person appointments. Randomization will be performed independently using an allocation sequence that will be kept concealed from clinical investigators. Contigo offers two primary functions: monitoring cancer patients’ progress and providing educational content to assist patients in managing common clinical situations related to their disease. The study will assess outcomes such as quality of life changes and depressive symptom development using validated scales, and adherence to in-person appointments. Specific scales include the EuroQol Group’s EQ-5D questionnaire and the Patient Health Questionnaire (PHQ-9). We hypothesize that the use of Contigo will assist and empower patients receiving cancer treatment, which will translate to better quality of life scores and a reduced incidence of depressive symptoms. All analyses will be undertaken with the intention-to-treat principle by a statistician unaware of treatment allocation. This trial is registered in ClinicalTrials under the registration number NCT06086990.</jats:p>Scopus© Citations 2 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 4 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 4 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The Link Between Information and Communication Technologies and Global Public Health: Pushing Forward(2013); ;Gladys Faba ;Manuel EspinozaGillian Santorelli1Scopus© Citations 22 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Scopus© Citations 2 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 2Scopus© Citations 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, ¿Como enfrentar el aumento de conductas individuales de riesgo para la salud en Chile?(2011); ;Manuel EspinozaPedro ZitkoScopus© Citations 2 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, ¿Cómo se ha medido la posición social en investigación en salud?: una revisión de la literatura internacional(2011); ;Pedro Zitko ;Rafael Pinedo ;Manuel EspinozaChristo AlborScopus© Citations 17 1